Table 1.
Vector | Composition | Target Gene | Nucleotide | Expression | Species | Route | Model | Year | Ref. |
---|---|---|---|---|---|---|---|---|---|
Liposomes | DOTMA, DOPE | SOD2 | plasmid | Up | mice | i.t. | bleomycin | 1999 | [48] |
Polycations | MAA-PEI | HGF | plasmid | Up | mice | i.v. | bleomycin | 2005 | [49] |
Liposomes | DharmaFECT™ 1 | SPARC | siRNA | down | mice | i.t. | radiation | 2010 | [50] |
Polycation | PEI | psTNFR-I | plasmid | Up | mice | i.m. | bleomycin | 2011 | [51] |
Polycations | PMAPEG, PDMAEMA | CTGF | siRNA | down | mice | i.t. | bleomycin | 2013 | [52] |
Polycations | DODMA, DSPC, PEG | AR or CTGF | siRNA | down | mice | i.t. | bleomycin | 2016 | [53] |
Liposomes | vitamin A, DC-6-14 | HSP47 | siRNA | down | rats | i.t. | bleomycin | 2017 | [54] |
Liposomes | NLCs-PGE2 | MMP3, CCL12, HIF1A | siRNA | down | mice | i.t. | bleomycin | 2017 | [55] |
Peptides | CADY peptide | SPARC, CCR2, SMAD3 | siRNA | down | mice | i.p. | bleomycin | 2018 | [56] |
Polycations | PEI-C22 | PAI-1 | siRNA | down | mice | i.t. | bleomycin | 2019 | [57] |
Polycations | F-PAMD | PAI-1 | siRNA | down | mice | i.t. | bleomycin | 2019 | [58] |
Liposomes | C12-200, mPEG-DMG | MBD2 | siRNA | down | mice | i.t. | bleomycin | 2021 | [59] |
Liposomes | C12-200, mPEG-DMG | SART1 | siRNA | down | mice | i.t. | bleomycin | 2021 | [60] |
Liposomes | C12-200, mPEG-DMG | SRPX2 | siRNA | down | mice | i.t. | bleomycin | 2021 | [61] |
Polycations | PEI-g-PEG-Mal | RUNX1 or Gli1 | siRNA | down | mice | i.v. | bleomycin | 2021 | [62] |
Liposomes | C12-200, mPEG-DMG | ACP5 | siRNA | down | mice | i.t. | bleomycin | 2022 | [63] |
Polycations | PFC nanoemulsions | STAT3 | siRNA | down | mice | i.t. | bleomycin | 2022 | [64] |